By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Miravant Medical Technologies 

7408 Hollister Avenue

Santa Barbara  California  93117  U.S.A.
Phone: 805-685-9880 Fax:



Company News
Miravant's (MRVT) Confirmatory Phase III Clinical Trial Of PHOTREX(TM) In Patients With Age-Related Macular Degeneration Is Underway10/19/2005 5:13:19 PM
Miravant (MRVT) Announces Fourth Quarter And 2004 Results10/19/2005 5:13:09 PM
Miravant (MRVT) To Initiate PHOTREX Confirmatory Phase III Clinical Trial In Europe; Global CRO Kendle Selected To Provide Clinical Development And Trial Management Services10/19/2005 5:12:59 PM
Miravant (MRVT) Obtains $15 Million Convertible Line Of Credit10/19/2005 5:12:57 PM
Miravant (MRVT) Completes $8 Million Funding10/19/2005 5:12:53 PM
Miravant (MRVT) To Conduct PHOTREX Confirmatory Study For Macular Degeneration10/19/2005 5:12:36 PM
Robert Sutcliffe And Michael Khoury Join Miravant (MRVT) Board Of Directors10/19/2005 5:12:35 PM
Miravant (MRVT) Announces Third Quarter Results For 200410/19/2005 5:12:13 PM
Miravant's (MRVT) Photrex -- SnET2 -- Presented At American Academy of Ophthalmology10/19/2005 5:11:55 PM
Miravant (MRVT) Enters Into Letter Of Intent For $15 Million Convertible Debt Line Of Credit10/19/2005 5:11:47 PM